Soleno
  • Company
    • Management
    • Board
    • Advisors
    • Careers
  • Product Candidate
    • DCCR
    • Mode of Action
    • Completed Studies
    • Clinical Trials
  • For Patients
    • Prader-Willi Syndrome
    • Patient Access
  • Investors
  • Contact us

Making a difference

Soleno Therapeutics, Inc.  is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.

We are committed to developing safe and effective therapeutic products that improve the lives of patients living with complex, life-threatening rare diseases with unmet medical needs.  

  • Management
  • Board
  • Advisors
  • Careers

We value team members who want to make a difference. For more information on career opportunities at Soleno, contact hr@soleno.life


Current Openings:

Associate Director/Director, Quality Systems

Senior Manager, Quality Assurance GCP

Senior Manager, Quality Control and Analytical Development

Clinical Research Associate II/Senior Clinical Research Associate

Clinical Research Associate

Manager to Director, Regulatory Affairs

Developing novel therapeutics for the treatment of rare diseases.

Pages

  • Company
    • Management
    • Boards
    • Advisors
    • Careers
  • For Patients
    • Prader-Willi Syndrome
  • Investors
  • Contact us

News and Events

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics Announces Financing Commitment for up to $60 Million

Contact Us

  • 203 Redwood Shores Parkway
  • Suite 500
  • Redwood City, CA 94065
  • Tel: (650) 213-8444
  • Email: info@soleno.life
  • Find us on Facebook

Soleno Therapeutics, Inc. © 2023 | All Rights Reserved

  • Terms of Use
  • Privacy Statement